Why Hoya Vivinex multiSert keeps eye surgeons loyal

Reviewed: ad hoc news Lifestyle & Consumer desk. Edited and checked on 2026-06-19, 04:54. Details in the imprint.

With Hoya Vivinex multiSert, the surgeon slides a tiny, folded lens through a narrow corneal incision, and for the patient the world suddenly sharpens again. The preloaded injector feels tidy in the hand, and the hydrophobic acrylic lens is designed to stay crystal clear for years.

What Vivinex multiSert promises

Vivinex multiSert is a foldable, hydrophobic acrylic intraocular lens for cataract surgery, delivered in a preloaded injector that lets surgeons choose between different insertion techniques in one system. The material aims for high optical clarity and low posterior capsule opacification over time.

The optics are built with a sharp square edge to discourage lens epithelial cells from creeping behind the implant, a design many surgeons value to keep patients from needing secondary laser treatment. Its aspheric profile is tuned to balance contrast sensitivity and depth of focus in everyday vision.

In the surgeon's hand

In the operating room, Vivinex multiSert feels like a quiet facilitator. The injector comes preloaded, so the scrub nurse does not have to wrestle a soft lens into a cartridge under time pressure, which reduces handling steps and the risk of contamination.

The tip is designed for small incisions, so the surgeon can glide the nozzle through a tight corneal tunnel and unfold the lens gently in the capsular bag. A controlled plunger movement gives a predictable release, which matters when the eye is already under fluid and viscoelastic stress.

How it differs from rivals

Compared with classic manually loaded lens systems, Vivinex multiSert cuts down on preparation complexity and standardizes the injection feeling across surgeons and hospitals. That consistency can ease training, especially in high volume cataract centers with rotating staff.

Hoya positions the Vivinex material as having a low incidence of glistenings, those tiny microvacuoles that can scatter light and annoy sensitive patients years after implantation. For surgeons, that promise of long term clarity is often a more convincing argument than a marginally sharper spec sheet.

Strengths in daily practice

For the patient, the win is largely invisible. They see a clear image and feel a fast recovery, helped by the small incision and stable lens position. Many will notice that night driving and reading in mixed light feel calm rather than harsh or washed out.

For the surgeon, the stable haptics and controlled unfolding reduce the number of micro adjustments needed in the capsular bag. That saves seconds in a procedure where every step is ritualized and where a single uncontrolled jump of the lens can spike the stress level.

Where compromises remain

Vivinex multiSert is not a Swiss army knife for every refractive wish. It is primarily a monofocal platform, so patients expecting spectacle independence for near tasks will still need reading glasses or additional strategies like monovision or separate premium lenses.

Pricing also tends to sit above basic bulk lenses that some public systems still favor, which can limit adoption in strictly cost driven tenders. Clinics must weigh the efficiency gains and potential reduction in postoperative interventions against the higher per case material bill.

Market role and stock angle

Within Hoya Corp's portfolio, Vivinex multiSert is one of the workhorse intraocular lens platforms that underpin the company's life care segment alongside eyeglass lenses and medical endoscopes. It expands Hoya's footprint in cataract surgery, a market that is growing structurally with aging populations worldwide.

Shares of Hoya Corp (JP3837800006) trade in Tokyo and are also accessible to European investors via listings in Frankfurt and on electronic platforms, but investors here mainly watch the earnings contribution of medical products like Vivinex rather than betting on short term price swings.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.